Experimental measles encephalitis in normal and cyclophosphamide-treated rhesus monkeys.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D001921:Brain / Q000382:microbiology; D002467:Cell Nucleus / Q000382:microbiology; D006224:Cricetinae; D003520:Cyclophosphamide / Q000009:adverse effects*; D004195:Disease Models, Animal; D004660:Encephalitis / Q000276:immunology / Q000382:microbiology* / Q000401:mortality / Q000473:pathology; D005455:Fluorescent Antibody Technique; D000882:Haplorhini; D006385:Hemagglutination Inhibition Tests; D006652:Histological Techniques; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007181:Inclusion Bodies, Viral; D007275:Injections, Intravenous; D008251:Macaca; D008459:Measles virus / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity*; D013045:Species Specificity; D013788:Thalamus / Q000473:pathology; D014776:Virus Cultivation
D000906:Antibodies; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide